The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: C-Terminal Insulin, Connecting peptide insulin, CPeptide, Insulin C-peptide, Proinsulin C-peptide
The C-Peptide test contains 1 test with 1 biomarker.
Brief Description: The C-Peptide test measures the level of C-peptide in the blood. C-peptide is a peptide chain released during the production of insulin by the pancreas. This test provides valuable information about insulin production and can help in the diagnosis and management of certain conditions related to insulin secretion.
Also Known As: Insulin C-Peptide Test, Connecting Peptide Insulin Test, Proinsulin C-peptide test
Collection Method: Blood Draw
Specimen Type: Serum
Test Preparation: Fasting is required.
A C-Peptide test may be ordered in the following situations:
Diabetes Diagnosis: A C-Peptide test is often used alongside other tests to distinguish between type 1 and type 2 diabetes. In individuals with type 1 diabetes, C-peptide levels are typically low or undetectable due to the destruction of insulin-producing beta cells in the pancreas. In contrast, individuals with type 2 diabetes usually have normal or high C-peptide levels as their pancreas continues to produce insulin.
Insulinoma: An insulinoma is a rare tumor of the pancreas that secretes excessive amounts of insulin. A C-Peptide test can help confirm the diagnosis by measuring elevated levels of C-peptide in the blood.
Assessing Insulin Production: A C-Peptide test may be ordered to evaluate insulin production in individuals with diabetes or other insulin-related conditions. It can help determine if the body is producing an appropriate amount of insulin in response to blood glucose levels.
C-peptide is a chemical made up of a short chain of amino acids that is released into the bloodstream as a byproduct of the pancreas producing insulin. This test determines how much C-peptide is present in a blood or urine sample.
Proinsulin, a physiologically inactive molecule, splits apart in the pancreas, within specialized cells called beta cells, to generate one molecule of C-peptide and one molecule of insulin. Insulin is necessary on a regular basis for the transport of glucose into the body's cells. When insulin is needed and released into the bloodstream in reaction to elevated glucose levels, equal amounts of C-peptide are also released. C-peptide can be used as a measure of insulin production because it is produced at the same rate as insulin.
C-peptide testing, in instance, can be used to assess the body's insulin production and distinguish it from insulin that is not produced by the body but is given as diabetes medication and hence does not generate C-peptide. This test can be done in conjunction with a blood test for insulin.
When a C-Peptide test is ordered, it's often part of a broader evaluation of diabetes or blood sugar control. Here are some tests commonly ordered alongside it:
Fasting Blood Glucose and Hemoglobin A1c (HbA1c):
GAD, IA-2, and Insulin Autoantibodies:
Urine Albumin/Creatinine Ratio (ACR):
These tests, when ordered alongside a C-Peptide test, provide a comprehensive view of an individual’s glucose metabolism, pancreatic function, and overall health status related to diabetes. They are crucial for diagnosing the type of diabetes, monitoring treatment, and managing diabetes-related complications. The specific combination of tests will depend on the individual's symptoms, medical history, and diabetes status.
A C-Peptide test may be required for the following conditions or diseases:
Diabetes: Differentiating between type 1 and type 2 diabetes is a common reason for ordering a C-Peptide test. Low or undetectable C-peptide levels indicate a lack of insulin production in type 1 diabetes, while normal or high levels suggest ongoing insulin production in type 2 diabetes.
Insulinoma: A C-Peptide test is essential for diagnosing insulinomas, which are pancreatic tumors that secrete excess insulin. Elevated C-peptide levels, along with accompanying symptoms, can help confirm the presence of an insulinoma.
Evaluation of Insulin Therapy: In individuals receiving insulin therapy, a C-Peptide test may be ordered to assess endogenous insulin production and evaluate the need for exogenous insulin.
C-peptide testing can be used for a variety of reasons. When proinsulin breaks into one molecule of C-peptide and one molecule of insulin, C-peptide is created by the beta cells in the pancreas. Insulin is a hormone that allows the body to use glucose as its primary energy source. C-peptide is a helpful measure of insulin production since it is produced at the same rate as insulin.
A C-peptide test is not used to diagnose diabetes; however, when a person is newly diagnosed with diabetes, it may be ordered alone or in conjunction with an insulin level to evaluate how much insulin the pancreas is currently making.
The body becomes resistant to the effects of insulin in type 2 diabetes, so it compensates by manufacturing and releasing more insulin, which can destroy beta cells. Oral medications are commonly used to help type 2 diabetics stimulate their bodies to produce more insulin and/or make their cells more receptive to the insulin that is already produced. Type 2 diabetics may eventually produce very little insulin as a result of beta cell loss, necessitating insulin injections. Because any insulin produced by the body is reflected in the C-peptide level, the C-peptide test can be used to track beta cell activity and capability over time and to assist a health care provider in deciding when to start insulin treatment.
Antibodies to insulin can develop in people on insulin therapy, independent of the source of the insulin. These often interfere with insulin assays, making it difficult to assess endogenous insulin production directly. C-peptide measurement is a good alternative to insulin testing in certain situations.
C-peptide levels can also be utilized in conjunction with insulin and glucose levels to help determine the source of hypoglycemia and track its therapy. Excessive insulin supplementation, alcohol intake, hereditary liver enzyme deficits, liver or kidney illness, or insulinomas can all cause hypoglycemia symptoms.
Insulinomas can be diagnosed with the C-peptide test. These are tumors of the pancreas' islet cells, which can produce excessive levels of insulin and C-peptide, resulting in abrupt hypoglycemia. C-peptide testing can be used to track how well insulinoma treatment is working and to detect recurrence.
A C-peptide test may be performed to help evaluate a person who has been diagnosed with metabolic syndrome, a group of risk factors that includes abdominal obesity, high blood pressure, and elevated blood glucose and/or insulin resistance.
C-peptide levels are occasionally used to verify the effectiveness of treatment and the procedure's sustained success after someone has had his pancreatic removed or has had pancreas islet cell transplants to restore the ability to manufacture insulin.
A high level of C-peptide implies that endogenous insulin synthesis is high. This could be a result of a high blood glucose level brought on by carbohydrate consumption and/or insulin resistance. Insulinomas, low blood potassium, Cushing syndrome, and renal failure are all linked to a high level of C-peptide.
C-peptide levels that are decreasing in someone with an insulinoma suggest a response to treatment when used for monitoring; levels that are increasing may indicate a tumor recurrence when used for monitoring.
A low amount of C-peptide is linked to a reduction in insulin synthesis. This can happen when the beta cells generate insufficient insulin, as in diabetes, or when their production is reduced by exogenous insulin administration.
What is the C-Peptide test?
The C-Peptide test measures the amount of this peptide in the blood. C-Peptide is a substance produced by the pancreas, and its levels can indicate how much insulin is being produced by the body.
Why would a C-Peptide test be ordered?
A C-Peptide test is ordered when a doctor wants to evaluate a patient's insulin production levels. It's often used to distinguish between type 1 and type 2 diabetes, and can also be used to determine whether a patient with diabetes is producing some of their own insulin.
What does a high C-Peptide test result mean?
A high C-Peptide level indicates that your body is producing a large amount of insulin. This could be due to insulin resistance (common in type 2 diabetes), a pancreatic tumor, or kidney disease, which slows the elimination of C-Peptide from the body.
What does a low C-Peptide test result mean?
A low C-Peptide level suggests that your body is not producing much insulin. This is common in type 1 diabetes and may also be seen in advanced stages of type 2 diabetes.
How is the C-Peptide test used in relation to diabetes?
The C-Peptide test can help distinguish between type 1 and type 2 diabetes. People with type 1 diabetes usually have low C-Peptide levels, indicating little to no insulin production, while those with type 2 often have normal or high levels, indicating their bodies are still producing insulin but are not using it effectively.
Can the C-Peptide test be used to monitor the effectiveness of diabetes treatment?
Yes, in some cases, the C-Peptide test can be used to monitor how well the body is producing insulin in response to treatment, especially in people with type 2 diabetes.
How is the C-Peptide test used in relation to insulinomas?
Insulinomas are tumors of the pancreas that produce excess insulin. A C-Peptide test can be used to confirm a diagnosis of an insulinoma, as these tumors typically result in high levels of both insulin and C-Peptide.
Can the C-Peptide test help in diagnosing hypoglycemia?
Yes, C-Peptide levels can help diagnose the cause of hypoglycemia (low blood sugar). Low C-Peptide levels suggest hypoglycemia is due to a lack of dietary intake, while high levels suggest excess insulin production.
Can I take medications before a C-Peptide test?
You should inform your healthcare provider about all medications you're taking, as some drugs can affect C-Peptide levels. They will advise if any changes are necessary.
How does a C-Peptide test differ from an insulin test?
Both tests are used to evaluate insulin production. However, C-Peptide is more stable and easier to measure than insulin, making it a more reliable indicator of insulin production.
Why is the C-Peptide test not used as frequently as other diabetes tests?
The C-Peptide test is more specialized and typically used when the distinction between type 1 and type 2 diabetes isn't clear from other tests, or to evaluate insulin production in people already diagnosed with diabetes.
Why might a C-Peptide test be repeated?
A C-Peptide test might be repeated to monitor changes in insulin production over time, especially in response to treatment for diabetes or an insulinoma.
How is the C-Peptide test used in relation to kidney function?
As the kidneys remove C-Peptide from the body, reduced kidney function can result in higher than normal C-Peptide levels. Therefore, kidney function can affect the interpretation of the C-Peptide test.
How can the C-Peptide test be useful in the treatment of type 1 diabetes?
In some cases, even people with type 1 diabetes can produce small amounts of insulin. Knowing this can help to tailor their insulin therapy.
Why do both insulin and C-Peptide get released in the body?
Insulin and C-Peptide are linked when initially produced as part of a larger molecule called proinsulin. When proinsulin is split to release insulin, C-Peptide is also released. The amount of C-Peptide can therefore be a marker of insulin production.
Can the C-Peptide test help identify the cause of postprandial hypoglycemia?
Yes, the C-Peptide test, especially when combined with an insulin level test, can help identify the cause of hypoglycemia occurring after meals (postprandial hypoglycemia).
Can the C-Peptide test help in determining the stage of diabetes?
C-Peptide levels can indicate how much insulin the body is producing, which can give some indication of the progression of diabetes, especially type 2 diabetes.
Can the C-Peptide test be used to predict the development of diabetic complications?
There is ongoing research into this area. Some studies suggest that lower C-Peptide levels may be associated with a higher risk of complications in type 1 diabetes, but further research is needed.
Can a C-Peptide test help to differentiate between MODY and type 1 diabetes?
Yes, individuals with MODY (Maturity Onset Diabetes of the Young) typically still produce some insulin, and therefore may have higher C-Peptide levels compared to those with type 1 diabetes.
Are there conditions other than diabetes where a C-Peptide test may be useful?
Yes, the C-Peptide test can also be useful in conditions involving abnormal insulin production, such as insulinomas, and in assessing hypoglycemia causes.
What factors can interfere with C-Peptide test results?
Factors like reduced kidney function, certain medications, and timing of sample collection in relation to meals can interfere with C-Peptide test results.
Can a C-Peptide test help to determine whether a person with diabetes can stop taking insulin?
In some cases, yes. A person with type 2 diabetes who has high C-Peptide levels is still producing insulin. If lifestyle changes or other medications improve their body's ability to use insulin effectively, they may be able to stop or reduce their insulin dosage.
Is the C-Peptide test useful in diagnosing gestational diabetes?
The C-Peptide test is not typically used in diagnosing gestational diabetes. A glucose challenge test or an oral glucose tolerance test are more commonly used.
Can the C-Peptide test be used to diagnose diabetes in children?
While the C-Peptide test can be used to assess insulin production in children, it is not typically the first choice for diagnosing diabetes in this population.
Can the C-Peptide test help to determine the success of a pancreas transplant?
Yes, C-Peptide levels can help assess the functioning of a transplanted pancreas, as rising levels can indicate that the new pancreas has begun to produce insulin.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.